Investment Trusts

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

Actions
  • Price (GBX)624.71
  • Today's Change-7.29 / -1.15%
  • Shares traded212.00
  • 1 Year change-5.06%
  • Beta0.1752
Data delayed at least 20 minutes, as of May 03 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Top holdings

34.31%Per cent of portfolio in top holdings
Holding% of portfolio
Amgen Inc5.65%
Cytokinetics Inc5.07%
Gilead Sciences Inc4.39%
Vera Therapeutics Inc Class A4.32%
Biomarin Pharmaceutical Inc4.31%
Incyte Corp3.66%
Supernus Pharmaceuticals Inc3.47%
Alnylam Pharmaceuticals Inc3.44%
As of Mar 31 2024. Top holdings excludes cash and cash equivalents.

Sector weighting

Sector% of portfolio
Healthcare100.87%
Consumer Defensive0.40%
As of Mar 31 2024.

Regional holdings

Holding% of portfolio
USA85.43%
China3.95%
UK2.84%
Netherlands2.63%
Denmark2.07%
Germany1.77%
Canada1.12%
Other1.48%
As of Mar 31 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.